Background: Although "universal precautions" are standard for sharps handling, there has been poor compliance among surgeons. We used video analysis to assess sharps handling practices among junior surgical residents.
Methods: Postgraduate year (PGY)-2 general surgery and PGY-1 plastic surgery residents were videotaped performing pediatric inguinal hernia repairs. For each procedure, the resident was the principal operator, with the attending surgeon assisting. Retrospective assessment of safe and unsafe sharps handling was determined based on published guidelines. We assessed safety performance in personal sharps tasks, passage of sharps and verbal notification regarding sharps. Data was analyzed using descriptive statistics.
Results: Data were collected from 18 residents' videos (4 plastic surgery, 14 general surgery). Residents safely performed sharps tasks, passed and verbally notified about sharps an average of 69.2%, 93.2% and 9.9% of the time, respectively. Suture needle manipulation was handled safely 56.2% of the time (mean 4.4 safe v. 4.3 unsafe actions). Surgical residents demonstrated a safe suture tying technique in 91.8% of cases, proper tissue retraction in 85.2% and safe handling of injection needles in 72.2% of cases. When assessing the safety performance of the surgical team, attending surgeons acting as surgical assistants safely passed sharps 80.0% of the time, while scrub nurses demonstrated safe passing at all times. Attending surgeons used verbal notification when passing sharps 22.7% of the time, while scrub nurses verbally notified the team 4.3% of the time.
Conclusion: Junior surgical residents consistently passed sharps safely. Personal sharps tasks were less likely to be performed safely, and only a minority of residents verbally notified the team about sharps placement.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432244 | PMC |
http://dx.doi.org/10.1503/cjs.031210 | DOI Listing |
Front Pediatr
January 2025
Infectious Diseases Research Laboratory, Research Division, Facultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México, Mexico.
Objective: The study aimed to describe the characteristics and risk factors associated with disease severity across six waves of COVID-19 in the pediatric population in Mexico.
Methods: A cohort study was conducted using data from the Mexican Ministry of Health, covering the period from March 2020 to March 2023. The dataset included patients under 18 years of age with confirmed SARS-CoV-2 infection.
Lancet Reg Health West Pac
January 2025
Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Background: Postprandial glucose concentration 1-h (1 h-PG) after an oral glucose tolerance test (OGTT) has similar or superior performance to 2 h-PG in predicting type-2 diabetes mellitus (T2DM) in several populations, and is simpler to obtain in clinical practice. However, studies in Asians are scarce. We investigated the utility of elevated baseline 1 h-PG in predicting T2DM incidence within three years, and its relationship with β-cell function in 1250 non-diabetic Asian participants.
View Article and Find Full Text PDFFront Pharmacol
January 2025
Department of Emergency, Peking University People's Hospital, Beijing, China.
Ceftriaxone is widely used in clinical practice for its efficacy against infections. However, its increasing association with life-threatening immune hemolytic reactions urge clinicians to enhance recognition and maintain sharp vigilance. This report details a rare and severe case of ceftriaxone-induced hemolytic anemia (CIHA), hemodynamic instability and hemolytic crisis in a 54-year-old woman after intravenous infusion of ceftriaxone following a respiratory infection.
View Article and Find Full Text PDFWellcome Open Res
November 2024
Lancaster Environment Centre, Lancaster University, Lancaster, England, UK.
We present a genome assembly from a juvenile male (the white-throated dipper; Chordata; Aves; Passeriformes; Cinclidae). The genome sequence has a total length of 1,170.80 megabases.
View Article and Find Full Text PDFPatient Relat Outcome Meas
January 2025
Merck & Co., Inc., Rahway, NJ, USA.
Introduction: The COVID-19 Symptoms Daily Diary (CSDD) is a patient-reported outcome measure designed to assess the severity of core COVID-19 symptoms in clinical trials. The preliminary version of the CSDD was developed based on regulatory guidance and the hallmark COVID-19 symptoms identified by the CDC. This study aimed to evaluate CSDD content validity, to determine whether it is fit for the purpose of supporting efficacy endpoints in clinical trials of treatments for COVID-19.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!